Search research articles
Contact Us
Filters
Showing results (31-40 of 114) with videos related to
Page
of 12
Sort By:
European Journal of Heart Failure
|
December 12, 2024
End-organ protective effect of serelaxin in patients hospitalized for heart failure: Results of the biomarker substudy of Relaxin in Acute Heart Failure-2 (RELAX-AHF-2)
Adriaan A Voors, Marco Metra, Douwe Postmus, et al.
European Journal of Heart Failure
|
July 18, 2023
Mineralocorticoid receptor antagonist initiation during admission is associated with improved outcomes irrespective of ejection fraction in patients with acute heart failure
Iris E Beldhuis, Kevin Damman, Peter S Pang, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society
|
March 19, 2011
Permutation criteria to evaluate multiple clinical endpoints in a proof-of-concept study: lessons from Pre-RELAX-AHF
Beth A Davison, Gad Cotter, Hengrui Sun, et al.
European Journal of Heart Failure
|
September 17, 2022
Characteristics and clinical outcomes of patients with acute heart failure with a supranormal left ventricular ejection fraction
Bart J van Essen, Jasper Tromp, Jozine M Ter Maaten, et al.
Heart Rhythm
|
April 26, 2016
Randomized, double-blind, placebo-controlled study to evaluate the safety and efficacy of a single oral dose of vanoxerine for the conversion of subjects with recent onset atrial fibrillation or flutter to normal sinus rhythm: RESTORE SR
Jonathan P Piccini, Edward L C Pritchett, Beth A Davison, et al.
JACC. Heart Failure
|
October 10, 2021
Association of Early Blood Pressure Decrease and Renal Function With Prognosis in Acute Heart Failure
Yuya Matsue, Iziah E Sama, Douwe Postmus, et al.
Circulation. Heart Failure
|
November 28, 2013
Predictors of postdischarge outcomes from information acquired shortly after admission for acute heart failure: a report from the Placebo-Controlled Randomized Study of the Selective A1 Adenosine Receptor Antagonist Rolofylline for Patients Hospitalized With Acute Decompensated Heart Failure and Volume Overload to Assess Treatment Effect on Congestion and Renal Function (PROTECT) Study
John G Cleland, Karen Chiswell, John R Teerlink, et al.
American Heart Journal
|
June 9, 2021
Regional variation of effects of new antidiabetic medications in cardiovascular outcome trials
Gad Cotter, Beth A Davison, Christopher Edwards, et al.
JACC. Heart Failure
|
April 4, 2016
Use of High-Sensitivity Troponin T to Identify Patients With Acute Heart Failure at Lower Risk for Adverse Outcomes: An Exploratory Analysis From the RELAX-AHF Trial
Peter S Pang, John R Teerlink, Adriaan A Voors, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society
|
February 3, 2017
Serelaxin in acute heart failure patients with and without atrial fibrillation: a secondary analysis of the RELAX-AHF trial
Gerasimos Filippatos, Dimitrios Farmakis, Marco Metra, et al.
Page
of 12
Search research articles
Search
Showing results (31-40 of 114) with videos related to
Sort By:
Page
of 12
European Journal of Heart Failure
|
December 12, 2024
End-organ protective effect of serelaxin in patients hospitalized for heart failure: Results of the biomarker substudy of Relaxin in Acute Heart Failure-2 (RELAX-AHF-2)
Adriaan A Voors, Marco Metra, Douwe Postmus, et al.
European Journal of Heart Failure
|
July 18, 2023
Mineralocorticoid receptor antagonist initiation during admission is associated with improved outcomes irrespective of ejection fraction in patients with acute heart failure
Iris E Beldhuis, Kevin Damman, Peter S Pang, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society
|
March 19, 2011
Permutation criteria to evaluate multiple clinical endpoints in a proof-of-concept study: lessons from Pre-RELAX-AHF
Beth A Davison, Gad Cotter, Hengrui Sun, et al.
European Journal of Heart Failure
|
September 17, 2022
Characteristics and clinical outcomes of patients with acute heart failure with a supranormal left ventricular ejection fraction
Bart J van Essen, Jasper Tromp, Jozine M Ter Maaten, et al.
Heart Rhythm
|
April 26, 2016
Randomized, double-blind, placebo-controlled study to evaluate the safety and efficacy of a single oral dose of vanoxerine for the conversion of subjects with recent onset atrial fibrillation or flutter to normal sinus rhythm: RESTORE SR
Jonathan P Piccini, Edward L C Pritchett, Beth A Davison, et al.
JACC. Heart Failure
|
October 10, 2021
Association of Early Blood Pressure Decrease and Renal Function With Prognosis in Acute Heart Failure
Yuya Matsue, Iziah E Sama, Douwe Postmus, et al.
Circulation. Heart Failure
|
November 28, 2013
Predictors of postdischarge outcomes from information acquired shortly after admission for acute heart failure: a report from the Placebo-Controlled Randomized Study of the Selective A1 Adenosine Receptor Antagonist Rolofylline for Patients Hospitalized With Acute Decompensated Heart Failure and Volume Overload to Assess Treatment Effect on Congestion and Renal Function (PROTECT) Study
John G Cleland, Karen Chiswell, John R Teerlink, et al.
American Heart Journal
|
June 9, 2021
Regional variation of effects of new antidiabetic medications in cardiovascular outcome trials
Gad Cotter, Beth A Davison, Christopher Edwards, et al.
JACC. Heart Failure
|
April 4, 2016
Use of High-Sensitivity Troponin T to Identify Patients With Acute Heart Failure at Lower Risk for Adverse Outcomes: An Exploratory Analysis From the RELAX-AHF Trial
Peter S Pang, John R Teerlink, Adriaan A Voors, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society
|
February 3, 2017
Serelaxin in acute heart failure patients with and without atrial fibrillation: a secondary analysis of the RELAX-AHF trial
Gerasimos Filippatos, Dimitrios Farmakis, Marco Metra, et al.
Page
of 12